Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.

Assessment of the Gastrointestinal System I: Subjective Data

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Seizures in brain tumor hospitalizations in the United States.

Frontiers in neurology·2026

Same author

Enhancing mental health resilience in the healthcare workforce during COVID-19: lessons from The North West Offer.

Future healthcare journal·2025

Same author

Cognitive debriefing of the Scleroderma Health Assessment Questionnaire in diffuse cutaneous systemic sclerosis.

Journal of scleroderma and related disorders·2025

Same author

Prevalence of Seizures in Hospitalizations with Traumatic Brain Injury: A U.S. Population-Based Study.

Neurotrauma reports·2025

Same author

How to improve the NHS: the public doesn't know the reality of the current service.

BMJ (Clinical research ed.)·2024

Same author

Reflections of a UK-based Indian doctor on promoting Indo-UK health collaboration.

The National medical journal of India·2024

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

The problem with NSAIDs: what data to believe?

Gayle McKellar¹, Rajan Madhok, Gurkirpal Singh

¹Center for Rheumatic Diseases, Glasgow Royal Infirmary, Castle Street, Glasgow G4 0SF, UK. gayle.mckellar@northglasgow.scot.nhs.uk

Current Pain and Headache Reports

|January 5, 2008

Summary

Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 inhibitors carry gastrointestinal and cardiovascular risks. Both drug classes now require black box warnings due to these serious safety concerns.

Related Experiment Videos

Last Updated: Jul 8, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

Area of Science:

Pharmacology
Gastroenterology
Cardiology

Background:

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for rheumatoid arthritis and osteoarthritis.
Selective cyclooxygenase-2 (COX-2) inhibitors were developed to improve gastrointestinal safety compared to traditional NSAIDs.

Purpose of the Study:

To review the gastrointestinal and cardiovascular risks associated with NSAIDs and selective COX-2 inhibitors.
To inform healthcare providers and patients about updated safety warnings.

Main Methods:

Literature review of studies on NSAIDs and COX-2 inhibitors.
Analysis of safety data regarding gastrointestinal and cardiovascular events.
Examination of regulatory agency recommendations.

Main Results:

Selective COX-2 inhibitors demonstrated improved gastrointestinal safety over traditional NSAIDs.
Both NSAIDs and selective COX-2 inhibitors are associated with increased serious cardiovascular risks.
Reevaluation of data revealed similar cardiovascular trends for both drug classes.

Conclusions:

Both traditional NSAIDs and selective COX-2 inhibitors pose significant gastrointestinal and cardiovascular risks.
The US Food and Drug Administration has mandated black box warnings for both drug classes.
Healthcare providers should carefully weigh the risks and benefits when prescribing these medications.